Voyager Therapeutics Inc VYGR Q1 2026 Earnings Narrowed Loss Meets Optimism in Gene Therapy Pipeline ALK Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Stock Gains Modestly Digi Power X Inc DGXX Q3 2025 Earnings Losses Narrow as Operational Focus Intensifies VABK Q1 2026 Earnings EPS of 097 Highlights Steady Performance Amid Limited Disclosure EVAX Q1 2026 Earnings WiderthanExpected Loss as Biotech Continues Development